after inter
on 27 Jan 2018
Last Applicant/ Owned by
Che Gong Miao, No. 6009 Shennan Road,
Futian Dist. Shenzhen
CN
518040
Serial Number
87425805 filed on 26th Apr 2017
Registration Number
N/A
Correspondent Address
TIMOTHY T WANG
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of a hexagon or cube shape formed by three L shapes of equal size. The top and bottom-right L shapes form an outward point, with the bottom-left L shape flipped, with the point going inward. LLL L L L Color is not claimed as a feature of the mark. Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, forRead More
Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
No 87425805
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.15.03 -
Incomplete polygons and polygons made of broken or dotted lines
26.15.28 -
Miscellaneous designs with overall polygon shape
26.19.04 -
Cubes
27.01.04 -
Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps
The mark consists of a hexagon or cube shape formed by three L shapes of equal size. The top and bottom-right L shapes form an outward point, with the bottom-left L shape flipped, with the point going inward.
| Status Date | Action Taken |
|---|---|
| 29th Jan 2018 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION |
| 27th Jan 2018 | OPPOSITION TERMINATED NO. 999999 |
| 27th Jan 2018 | ABANDONMENT - AFTER INTER PARTES DECISION |
| 27th Jan 2018 | OPPOSITION SUSTAINED NO. 999999 |
| 19th Oct 2017 | OPPOSITION INSTITUTED NO. 999999 |
| 19th Oct 2017 | OPPOSITION PAPERS RECEIVED AT TTAB |
| 19th Sep 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Sep 2017 | PUBLISHED FOR OPPOSITION |
| 30th Aug 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Jul 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
